Life Science News
Latest updates from the biotech and pharma world
Novartis wins approval to use SMA gene therapy in older patients
Gilead scoops up a preclinical cancer program
How do Big Pharma employees rate their CEOs?
Kelun, Merck tout ADC as potential first-line treatment in lung cancer
Bayer’s experimental blood-thinner notches trial win in stroke prevention
#Asundexian Phase#prevention Asundexian#study results#clinical setbacks#Phase
Novo Nordisk’s GLP-1 misses goal in closely watched Alzheimer’s studies
#Novo Nordisk#watched Alzheimer#misses goal#heart health#combat neurodegeneration
FDA probes effects of Takeda rare disease drug after patient death
#FDA probes#Takeda rare#neutralizing antibodies#probes effects#rare disease
Biogen strikes deal with Versant-backed biotech to expand immune portfolio
#Dayra Therapeutics#Versant-backed biotech#portfolio Newly#Newly launched#launched Dayra
APOE4 and CRISPR are reframing Alzheimer’s Risk
#reframing Alzheimer#CRISPR brings#slowing Alzheimer#brings hope#CRISPR
Eli Lilly becomes first drugmaker to hit $1 trillion in market value
#Eli Lilly#drugmaking peers#pharmaceutical company#success developing#developing medicines
FDA tests new program to speed drugmaker talks; Bezos-linked AI startup raises $106M
#quick clarifications#FDA tests#drugmaker talks#speed drugmaker#agency staff
GSK, Anaptysbio sue each other over Jemperli revenue
#Jemperli revenue#royalty business#cancer immunotherapy#Anaptysbio sue#Anaptysbio seeks
A brain biotech’s top drug fails against MS
#Contineum Therapeutics#Therapeutics dipped#late Thursday#piqued Johnson#brain biotech
Moderna secures $1.5B lifeline as it looks to break even in 2028
#Moderna secures#day event#disease programs#analyst day#invest revenue
Roche pill notches win in early breast cancer - BioPharma Dive
#Roche pill#BioPharma Dive#pill notches#notches win#early breast
Roche’s MS tablet scores in late-stage studies - BioPharma Dive
#BioPharma Dive#tablet scores#Dive Roche#late-stage studies#Dive
Roche taps an AI specialist to craft new brain drugs - BioPharma Dive
#Roche taps#BioPharma Dive#Dive Roche#brain drugs#Dive
Roche dives into MASH with $2.4B deal for 89bio - BioPharma Dive
#BioPharma Dive#Roche dives#Dive Roche#MASH#deal
Illumina to buy SomaLogic in deal worth up to $425M - BioPharma Dive
#BioPharma Dive#buy SomaLogic#deal worth#Dive Illumina#Dive